Isolation and screening of bioactive principle from Chaetomorpha antennina against certain bacterial strains.

Microbial pathogens develop resistance to a particular antibiotic after repeated administration during the treatment of infectious diseases. Moreover, multiple drug resistance is a very common problem especially in hospital acquired infections. Therefore, it is necessary to find out alternative antibacterial drugs and the present trend is focused on seaweeds. This preliminary research work was carried out to find out the antibacterial activity of petroleum ether extract of Chaetomorpha antennina. The extracts were tested against Staphylococcus aureus MTCC 121, Bacillus cereus MTCC 492, Bacillus subtilis MTCC 441, Klebsiella pneumoniae MTCC 530, Escherichia coli MTCC 443 and Pseudomonas aeruginosa MTCC 779 by agar well diffusion technique. It was observed that petroleum ether extract showed prominent zone of inhibition against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus even at 50 µg/ml concentration. The maximum spectrum of activity was observed against Staphylococcus aureus ranged from 7.3 ± 0.8 to 18 ± 2.4 mm at the concentration 50 to 500 µg/ml, respectively. Hence the most susceptible bacterium was Staphylococcus aureus among the tested organisms. However, Escherichia coli and Pseudomonas aeruginosa are also susceptible. But the Bacillus cereus and Klebsiella pneumoniae are resistant against the tested extract.

Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.

The strategy of World Health Organization is to develop efficient and inexpensive vaccine against various infectious diseases amongst children's population. Vaccination is considered as the most cost effective health intervention known to public. Since 90 years various substances have been added in vaccine formulation but still alum is considered as the safest adjuvant for human use licensed by United States Food and Drug Administration. MF 59 and ASO4 are the adjuvants were developed recently and approved for human use. Due to poor adjuvancity, conventional vaccines require multiple recall injection at approximately time intervals to attain optimal immune response. For past approximately two decades the vaccine research has been focused towards the alternation of alum type of adjuvant in order to increase the immunogenicity. The development of new vaccines, is more efficacious or easier to deliver, or both have become an area of research that can certainly benefit from controlled release technology. Especially, the conversion of multiple administration vaccine into single administration vaccine may represent an improved advancement towards the betterment of human health care and welfare. Biodegradable polymer microparticles have been evaluated for delivering antigens in native form, sustained release keeping in mind the safety aspects. In this article we review the overall concept of adjuvants in vaccine technology with special focus towards the prospects of controlled release antigens.

Influence of viscoelasticity of protein on the toughness of bone.

Bone is an ultrafine composite of protein (collagen) and mineral (hydroxyapatite). An analysis to determine the influence of the viscoelasticity of protein on the toughness of bone at the ultrafine scale is conducted by developing a discrete lattice model appropriate for the ultrafine scale called the incremental continuous damage random fuse model (ICDRFM). Collagen viscoelasticity at ultrafine scale is shown to contribute significantly to the toughness of bone. The results obtained are important in the design of biomimetic ultratough artificial composites.

Larvicidal activity of Saraca indica, Nyctanthes arbor-tristis, and Clitoria ternatea extracts against three mosquito vector species.

Screening of natural products for mosquito larvicidal activity against three major mosquito vectors Aedes aegypti, Culex quinquefasciatus, and Anopheles stephensi resulted in the identification of three potential plant extracts viz., Saraca indica/asoca, Nyctanthes arbor-tristis, and Clitoria ternatea for mosquito larval control. In the case of S. indica/asoca, the petroleum ether extract of the leaves and the chloroform extract of the bark were effective against the larvae of C. quinquefasciatus with respective LC(50) values 228.9 and 291.5 ppm. The LC(50) values of chloroform extract of N. arbor-tristis leaves were 303.2, 518.2, and 420.2 ppm against A. aegypti, A. stephensi, and C. quinquefasciatus, respectively. The methanol and chloroform extracts of flowers of N. arbor-tristis showed larvicidal activity against larvae of A. stephensi with the respective LC(50) values of 244.4 and 747.7 ppm. Among the methanol extracts of C. ternatea leaves, roots, flowers, and seeds, the seed extract was effective against the larvae of all the three species with LC(50) values 65.2, 154.5, and 54.4 ppm, respectively, for A. stephensi, A. aegypti, and C. quinquefasciatus. Among the three plant species studied for mosquito larvicidal activity, C. ternatea was showing the most promising mosquito larvicidal activity. The phytochemical analysis of the promising methanolic extract of the seed extract was positive for carbohydrates, saponins, terpenoids, tannins, and proteins. In conclusion, bioassay-guided fractionation of effective extracts may result in identification of a useful molecule for the control of mosquito vectors.

Immune Augmentation of Single Contact Hepatitis B Vaccine by Using PLGA Microspheres as an Adjuvant.

The present study was aimed to replace the alum type adjuvant for hepatitis B vaccine. The hepatitis B vaccine was encapsulated in poly (DL-lactide-co-glycolide) microspheres by solvent evaporation technique. The formulated microspheres were characterized in terms of morphology, particle size analysis, in vitro release study and in vivo immune response in male Wistar rats. The FT IR spectrum illustrates the characteristics bands of poly (DL-lactide-co-glycolide) microspheres and hepatitis B vaccine at 1750 cm(-1) and 1650 cm(-1), respectively. The hepatitis B vaccine loaded poly (DL-lactide-co-glycolide) microspheres were able to release antigens till day 42. Significant enhancement of specific antibodies to HBsAg was produced till day 90 after a single administration of HBsAg encapsulated poly (DL-lactide-co-glycolide) microspheres. However, the conventional alum adsorbed hepatitis B vaccine was not found to produce any significant specific antibody levels till day 90 after a single dose. The results showed that poly (DL-lactide-co-glycolide) microspheres show potential as an adjuvant for hepatitis B vaccine.